What's New on the FDA Drugs Site
May 20, 2015
- FDA Drug Safety Communication: FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam)
- Drugs@FDA Data Files (updated)
- Manual of Policies and Procedures (MAPP) 4512.2 Rev 1 Conducting Effective Meetings in CDER: Remote Access Considerations (PDF - 113KB)
- Pediatric Medical, Statistical, and Clinical Pharmacology BPCA Reviews (updated)
- Postmarketing Requirements and Commitments: Downloadable Database File
- Postmarket Requirements and Commitments Search
- Warning Letters 2015 (updated)
.png)
No hay comentarios:
Publicar un comentario